Stock Quote
Biopure Corporation (BPUR.OQ) (NASDAQ Stock Exchange Capital Market)
$0.00
--
+0.00%
$0.00
--
0
$0.00
$0.00
$0.00
$0.00
0.00
0
No news stories for this company within the last 30 days.
BPUR.OQ
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Zafirelis, Zafiris | Chairman of the Board, President, Chief Executive Officer | 284,121 |
| Judelson, David | Vice Chairman of the Board | -- |
| Kober, Jane | Senior Vice President, General Counsel and Secretary | 340,086 |
Profile
Biopure Corporation (Biopure) develops oxygen therapeutics, which are intravenously administered to deliver oxygen to the body’s tissues. Its products are Oxyglobin, for veterinary use, and Hemopure, for human use. The Company, through distributors, sells Oxyglobin in the United States and Europe... Full Description
Company Address
Biopure Corporation
11 Hurley Street
Cambridge MA 02141
P: +1617.2346500
F: +1617.2346505
11 Hurley Street
Cambridge MA 02141
P: +1617.2346500
F: +1617.2346505
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Northfield Laboratories | $0.04 | 0.00 |
| BPUR.OQ | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.60 |
| P/S(TTM) | 0.20 | 0.57 |
| ROI(TTM) | -155.41 | 1.86 |
| ROE(TTM) | -166.47 | 2.52 |
No consensus estimates data available.
| Total Revenue | $0.35M |
| Net Income | $-1.79M |
| EPS | $-0.05 |
